Gineva

Antineoplastic agent. Indicated as treatment for specific tumors in adults (advanced RH+ breast cancer, renal cancer, subependymal giant cell astrocytoma, advanced neuroendocrine tumors), and to prevent the growth of other noncancerous cells associated with a genetic disorder called tuberous sclerosis (TS) in children or adults.

Therapeutic Area
Oncology

Active Ingredient
Everolimus

Line
Oncology

Dosage forms
5 mg x 30 tablets
10 mg x 30 tablets